Загрузка...
Improving and maintaining responses in pediatric B-ALL CAR-T therapy
CAR T therapy has heralded a new era in the treatment of acute lymphoblastic leukemia (ALL) and other hematologic malignancies. In this autologous immunotherapy, patient derived T cells are genetically engineered and then infused back to kill the leukemia cells. The observed response rates in ALL ar...
Сохранить в:
| Опубликовано в: : | Cancer J |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8130572/ https://ncbi.nlm.nih.gov/pubmed/33750075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000513 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|